Skip to Content

WARRICK 1621 (Griseofulvin (Ultramicrocrystalline) 250 mg)

Pill with imprint WARRICK 1621 is White, Round and has been identified as Griseofulvin (Ultramicrocrystalline) 250 mg. It is supplied by ESI Lederle Generics.

Griseofulvin is used in the treatment of dermatophytosis; onychomycosis, toenail; tinea barbae; onychomycosis, fingernail; tinea capitis and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WARRICK 1621

Griseofulvin (ultramicrocrystalline) 250 mg WARRICK 1621

Griseofulvin (Ultramicrocrystalline)

Imprint
WARRICK 1621
Strength
250 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous antifungals
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
ESI Lederle Generics
National Drug Code (NDC)
59911-5805

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.